Project Id BITS025F001431
Project Detail
Project Title Efflux pump inhibitor enhanced antimicrobial peptide-based nanozyme for AMR reversal
Senior Supervision Team (BITS)
Supervisor name and Title Professor Jayati Ray Dutta School or Department (or company, if applicable) BITS PILANI, HYDERABAD CAMPUS
Email ID jayati@hyderabad.bits-pilani.ac.in
URL for more info https://www.bits-pilani.ac.in/hyderabad/prof-jayati-ray-dutta/
a) Are you currently supervising a BITS or RMIT HDR student? YES
Please comment how many you are supervising 8
b) Have you supervised an offshore candidate before? NO
If no, what support structures do you have in place?
If yes, please elaborate N
Senior Supervision Team (RMIT)
Supervisor name and Title A/Prof. Yichao Wang School or Department (or company, if applicable) STEM
Email ID yichao.wang@rmit.edu.au
URL for more info https://www.rmit.edu.au/profiles/w/yichao-wang
a) Are you currently supervising a BITS or RMIT HDR student? YES
Please comment how many you are supervising 1
b) Have you supervised an offshore candidate before? YES
If no, what support structures do you have in place?
If yes, please elaborate Served as the external supervisor for a Master’s candidate at Qingdao University of Science adn Technology and collaboratively published a paper in Advanced Functional Materials, 2024, 34, 2407336
Other Supervisors (BITS)
Supervisor name and Title Ramakrishnan Ganesan School or Department (or company, if applicable) BITS PILANI, HYDERABAD CAMPUS
Phone Number (Optional) 04066303602 Email ID ram.ganesan@hyderabad.bits-pilani.ac.in
URL for more info https://universe.bits-pilani.ac.in/hyderabad/ram/Profile
Other Supervisors (BITS)
Supervisor name and Title Professor Ravi Shukla School or Department (or company, if applicable) STEM
Phone Number (Optional) +61 3 9925 22970 Email ID ravi.shukla@rmit.edu.au
URL for more info https://www.rmit.edu.au/contact/staff-contacts/academic-staff/s/shukla-associate-professor-ravi
Field of Research (For Codes)
Research CodeResearch AreaResearch Percent
310607Nanobiotechnology30.00
310701Bacteriology40.00
340301Inorganic materials (incl. nanomaterials)30.00
Project Description
Summary: Antimicrobial resistance (AMR) poses a significant threat to global health, often driven by bacterial efflux pumps that expel antibiotics, reducing their efficacy. This proposal explores a novel strategy to combat AMR by combining an efflux pump inhibitor (EPI) with an antimicrobial peptide-based nanozyme. The nanozyme enhances bacterial killing through catalytic activity while the EPI prevents drug expulsion, ensuring higher intracellular drug retention. This synergistic approach aims to restore antibiotic susceptibility and improve therapeutic outcomes against resistant pathogens. By integrating nanotechnology and biochemical inhibition, this platform offers a promising alternative to conventional antibiotics, potentially overcoming resistance mechanisms and enhancing treatment efficacy. The findings could pave the way for innovative antimicrobial strategies to tackle multidrug-resistant bacterial infections. Aims: 1) To develop and characterize the antimicrobial peptide-based nanozyme (BITS-9 months) 2) To evaluate the synergistic effect of the Efflux pump inhibitor and nanozyme (RMIT-12 months) 3) To assess the mechanism and potential for AMR reversal (BITS-12 months) Methodology: 1. Development and characterization of antimicrobial peptide-based nanozyme for stability, catalytic activity and cytotoxicity. 2. Evaluation of the synergistic efficacy of Efflux pump inhibitor and nanozyme and assessing their therapeutic potential in vitro using MIC/MBC assays. 3. Investigation of the mechanism and potential of EPI-AMP based nanozyme for AMR reversal through RT-qPCR, RNA sequencing, passaging and proteomics.
Project Deliverable/Outcomes
One of the major outcomes of the proposal is the development of a novel antimicrobial platform: A well-characterized antimicrobial peptide-based nanozyme with enhanced catalytic activity, stability, and minimal cytotoxicity. - With the successful testing through in vitro/in vivo studies, the developed nanozyme will establish the feasibility for future preclinical studies, offering a promising alternative to conventional antibiotics for treating multidrug-resistant infections. - This approach will also contribute to the scientific community by providing novel insights into efflux pump inhibition and nanozyme-based antimicrobial strategies, paving the way for future translational applications. - The project shall also contribute to human resource development to the tune of one doctoral candidate and also provide exposure to the undergraduate students with the state-of-the-art research exposure. - A minimum of three research articles in internationally reputed journals will arise from the project. - The successful implementation of the proposal is envisioned to result in IPR filing in India and abroad. - The research can also lead to industry collaboration. The project outcome will be shared with relevant industries through workshops, and also direct meetings.
Research Impact Themes
ThemeSubtheme
BETTER HEALTH OUTCOMESBIOTECHNOLOGY
Life sciencesBiotechnology and Bioengineering
ADVANCED MATERIALS, MANUFACTURING AND FABRICATIONSPECIALISED MATERIALS
Which RMIT Sustainable Development Goal (SDG) does your project align to
GOOD HEALTH AND WELLBEING
Which RMIT Enabling Impact Platform (EIP) does your project align to
BIOMEDICAL AND HEALTH INNOVATION
Which RMIT Program code will this project sit under?
DR229 (CHEM AND ENVIRO)
Student Capabilities and Qualifications
Background on Biochemistry/Materials Science/Biological Sciences
Cell culture, in vitro/ in vivo culture,microbiological techniques, material design/synthesis
Masters by research/ MTech in Microbiology/Materials Science/Biotechnology/Biochemistry
Preferred discipline of Student
Discipline
Biotechnology
Health, Digital Health
Materials Chemistry
Nanotechnology, Nanomaterials, Nanomedicine, Nanoscience
IP Address : ::1
Date of Downloading : 6/1/2025 12:47:30 PM